Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?

While the elevated lifetime risk of breast and ovarian cancer is well recognised for patients with a BRCA mutation, the implementation of effective risk reduction strategies has been fraught with challenges. This report from an international database and published in the British Journal of Cancer re...

Descripción completa

Detalles Bibliográficos
Autores principales: LeVasseur, Nathalie, Chia, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738056/
https://www.ncbi.nlm.nih.gov/pubmed/31171836
http://dx.doi.org/10.1038/s41416-019-0484-8
_version_ 1783450773638610944
author LeVasseur, Nathalie
Chia, Stephen
author_facet LeVasseur, Nathalie
Chia, Stephen
author_sort LeVasseur, Nathalie
collection PubMed
description While the elevated lifetime risk of breast and ovarian cancer is well recognised for patients with a BRCA mutation, the implementation of effective risk reduction strategies has been fraught with challenges. This report from an international database and published in the British Journal of Cancer reveals suboptimal rates of utilisation of surveillance/preventative measures globally.
format Online
Article
Text
id pubmed-6738056
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67380562020-06-07 Cancer screening and prevention in BRCA mutation carriers: a missed opportunity? LeVasseur, Nathalie Chia, Stephen Br J Cancer Editorial While the elevated lifetime risk of breast and ovarian cancer is well recognised for patients with a BRCA mutation, the implementation of effective risk reduction strategies has been fraught with challenges. This report from an international database and published in the British Journal of Cancer reveals suboptimal rates of utilisation of surveillance/preventative measures globally. Nature Publishing Group UK 2019-06-07 2019-07-02 /pmc/articles/PMC6738056/ /pubmed/31171836 http://dx.doi.org/10.1038/s41416-019-0484-8 Text en © Cancer Research UK 2019 https://creativecommons.org/licenses/by/4.0/This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Editorial
LeVasseur, Nathalie
Chia, Stephen
Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
title Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
title_full Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
title_fullStr Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
title_full_unstemmed Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
title_short Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
title_sort cancer screening and prevention in brca mutation carriers: a missed opportunity?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738056/
https://www.ncbi.nlm.nih.gov/pubmed/31171836
http://dx.doi.org/10.1038/s41416-019-0484-8
work_keys_str_mv AT levasseurnathalie cancerscreeningandpreventioninbrcamutationcarriersamissedopportunity
AT chiastephen cancerscreeningandpreventioninbrcamutationcarriersamissedopportunity

Ejemplares similares